1 / 38

Board Review: Neurology

Board Review: Neurology. Matthew Volk 6/5/2009. MKSAP Question #1. Guillain-Barre Syndrome. Immune-mediated, demyelinating polyneuropathy Proximal and distal weakness – including respiratory failure; Distal sensory loss Autonomic and cranial nerve involvement

yonah
Download Presentation

Board Review: Neurology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Board Review: Neurology Matthew Volk 6/5/2009

  2. MKSAP Question #1

  3. Guillain-Barre Syndrome • Immune-mediated, demyelinating polyneuropathy • Proximal and distal weakness – including respiratory failure; Distal sensory loss • Autonomic and cranial nerve involvement • Most cases triggered by infxn, surgery, or immunization • CMV, EBV, HIV, Hepatitis, Lyme, campylobacter jejuni

  4. Guillain-Barre Syndrome • Treatment • Supportive care • Follow FVC and NIFs • Mechanic ventilation as needed • IVIg – avoid in CKD, CHF, IgA deficiency • Plasmapheresis – avoid in infxn, low BP • No benefit to combination therapy • Steroids not shown to help

  5. MKSAP Question #2

  6. MKSAP Question #2

  7. Acute Ischemic Stroke • Inclusion criteria for tPA • Age >18 years • Clinical diagnosis of ischemic stroke • Onset of symptoms within 3 hours of rx • CT without evidence of ICH • Key exclusion criteria • Rapidly improving symptoms • Persistent BP > 185/110

  8. Acute Ischemic Stroke • Aspirin to reduce rate of recurrent stroke; effect within 2 weeks • Subcutaneous heparin to prevent DVT • Airway protection/dysphagia screening • Blood pressure control in certain cases • Maintainence of normothermia • Hypothermia not studied in acute stroke • Aim for normoglycemia

  9. Acute Ischemic Stroke More on Blood Pressure control: • Hypertension protective unless extreme • Many would not treat unless >220 systolic • EXCEPT treat to goal 140-150 with MI, aortic dissection, hemorrhagic conversion • Recommended agents • Nicardipine, labetalol, nitroprusside

  10. MKSAP Question #3

  11. Parkinsonism • Drug-induced Parkinsonism • Antiemetics, Antipsychotics, CCBs • Reversible with removal of offending agent • Neurodegenerative processes • Progressive Supranuclear Palsy • Multiple System Atrophy • Corticobasal Degeneration • Huntington’s Disease

  12. Parkinsonism • Essential Tremor • Restless Leg Syndrome • Focal/generalized dystonias • Cervical dystonia • Blepharospasm • Oromandibular dystonia • Spasmotic dysphonia • Ideopathic Parkinson’s Disease

  13. Parkinson’s Disease • Symptoms: resting tremor, rigidity, bradykinesia, postural instability • Treatments • Levodopa/carbidopa – older patients • Dopamine agonists – young patients • Amantadine – mainly works with tremor • Anticholinergics – young patients • MAO inhibitors – adjunctive therapy

  14. MKSAP Question #4

  15. Multiple Sclerosis • Signs and Symptoms – develop over hours to days to years • Diplopia or Optic Neuritis • Hemiparesis • Hemisensory disturbance • Band-like sensations around trunk • Urinary retention • Cognitive decline

  16. Multiple Sclerosis • Treatment • Solumedrol followed by prednisone taper in acute exacerbations • Disease-modifying therapy – for relapsing-remitting disease • Interferon beta (Betaseron, Avonex, Rebif) • Glatiramer acetate (MHC interaction) • Combination therapy – for progressive dz • Combine with cyclophos or Mitoxantrone

  17. MKSAP Question #5

  18. Migraine Headaches • Throbbing pain with photophobia and phonophobia. • Brainstem involvement results in nausea, pallor, flushing, tearing, rhinorrhea, and sinus congestion. • 60-70% with prodrome 24 hr prior • 15-25% with aura 1 hr prior

  19. Migraine Headaches • Treatment • NSAIDs – nonspecific; for mild headaches • Triptans – direct trigeminal nerve binding; for moderate to severe headaches • Contraindicated in CAD • Ergot derivatives – hospitalized patients • Rescue medications – Haldol, lidocaine, magnesium, dilantin, tizanidine, zyprexa. • Opioids can be used occasionally

  20. MKSAP Question #6

  21. MKSAP Question #7

  22. Epilepsy • Two or more unprovoked seizures • Etiologies: unknown (ideopathic) or focal abn (symptomatic) • Vascular malformation • Tumor • Restricted scar • Focal cortical dysgenesis

  23. Epilepsy Treatment • After first seizure – decision to start treatment is individualized • No driving for 6 months to 1 year • Risk for recurrence is 30 to 60%. • Abnormal EEG indicates higher risk • After second seizure recurrance rate is 80 to 90%.

  24. Epilepsy Treatment • Choice of medication • Absence – Ethosuximide • GTC – Phenytoin, Carbamazepine, Phenobarbital, Valproate • Partial – Gabapentin, Lamotrigine, topiramaate, oxcarbazepine • Cognitive impairment – Phenobarb, Phenytoin, Carbamazepine, Topiramate

  25. Status Epilepticus • Secure ABCs – including intubation • Ativan 0.1 mg/kg then • Phenytoin/phos-phenytoin 18 mg/kg • Phenobarbitol 15 mg/kg • Pentobarbitol 5-15 mg/kg

  26. MKSAP Question #8

  27. MKSAP Question #8

  28. Primary CNS Lymphoma • Presentation: confusion, lethargy, memory loss, focal neuro signs, and/or seizures • Solitary or multiple brain masses • Diagnostic evaluation • Evaluation for uveitis, retinitis • CSF EBV viral load • brain biopsy • Treat with MTX and whole brain XRT

  29. Toxoplasmic Encephalitis • Similar presentation to PCNSL • Diagnostic criteria • Seropositive for Toxo IgG antibody • CD4 < 100 and not getting prophy • Multiple ring-enhancing lesions on MRI • If all three present 90% likelihood • Presumptive pyrimethamine/sulfadiazine • Otherwise brain biopsy recommended.

  30. MKSAP Question #9

  31. Compressive myelopathy • Presentation: • Initial spinal or radicular pain • Bilateral motor or sensory dysfxn • No brain or brainstem findings • Evaluate with MRI spine • Surgical decompression for epidural abscess and spondylosis • Steroids and XRT vs. surgery for epidural tumors

  32. MKSAP Question #10

  33. MKSAP Question #10

  34. MKSAP Question #10

  35. MKSAP Question #10

  36. Viral Encephalitis • Symptoms of encephalitis • AMS – subtle to unresponsive • Usually no meningeal signs • Seizures common • Focal neurologic findings; abn reflexes • CT/MRI Findings • VZV, HSV, HHV-6 – temporal lobe • West Nile – temporal lobe, basal ganglia, thalamus, brainstem, cerebellum

  37. Viral Encephalitis • CSF Findings • Elevated protein but <150 mg/dl • Normal glucose • Elevated WBC count but <250/mm3 • No red cells except in HSV

  38. References • MKSAP 14 – Neurology • MKSAP 14 – Infectious Disease • Uptodate Online

More Related